A novel amperometric biosensor based on gold nanoparticles anchored on reduced graphene oxide for sensitive detection of L-lactate tumor biomarker

In this work, a novel amperometric biosensor based on gold nanoparticles anchored on reduced graphene oxide (RGO-AuNPs) and L-lactate dehydrogenase (LDH) was developed for the sensing of Llactate. Firstly, the RGO-AuNPs modified screen printed electrodes were tested for NADH detection showing a wide...

Descripción completa

Detalles Bibliográficos
Autores: Azzouzi, Sawsen, Rotariua, Lucian, Benito, Ana M., Maser, Wolfgang K., Ben Alib, Mounir, Bala, Camelia
Tipo de recurso: artículo
Estado:Versión aceptada para publicación
Fecha de publicación:2015
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/123523
Acceso en línea:http://hdl.handle.net/10261/123523
Access Level:acceso abierto
Palabra clave:Reduced graphene oxide
Gold nanoparticles
NADH
L-lactate
Cancer biomarkers
L-lactate dehydrogenase
Descripción
Sumario:In this work, a novel amperometric biosensor based on gold nanoparticles anchored on reduced graphene oxide (RGO-AuNPs) and L-lactate dehydrogenase (LDH) was developed for the sensing of Llactate. Firstly, the RGO-AuNPs modified screen printed electrodes were tested for NADH detection showing a wide dynamic range and a low detection limit. Next, the biosensor was constructed by incorporating both enzyme and RGO-AuNPs in a sol gel matrix derived from tetrametoxysilane and methyltrimetoxysilane. The enzyme loading, working pH, and coenzyme concentration were optimized. The biosensor linearly responded to L-lactate in the range of 10 μM - 5 mM and showed a good specific sensitivity of 154 μA/mM·cm2 with a detection limit of 0.13 μM. This was accompanied by good reproducibility and operational stability. Tests on artificial serum proved that L-lactate can be determined practically without interferences from commonly interfering compounds such as urate, paracetamol and L-ascorbate. Our LDH/RGO-AuNPs/SPCE based biosensor thus performs as electrochemical device for the detection of L-lactate as a viable early cancer bio-marker.